Showing results (431-440 of 645) with videos related to

Sort By:
Pageof 65
The American Journal of Pathology|October 1, 1995
p53-independent expression of the cyclin-dependent kinase inhibitor p21 in pancreatic carcinomaJ A DiGiuseppe, M S Redston, C J Yeo, et al.
Journal of Hepato-Biliary-Pancreatic Surgery|May 22, 2002
Hereditary factors in pancreatic cancerHenry T Lynch, Randall E Brand, Jane F Lynch, et al.
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|February 28, 2001
Impact of the initial doses of rocuronium and pancuronium on subsequent maintenance for neuromuscular blockS E Kern, R J Fragen, P C Fitzgerald, et al.
Pharmaceutical Research|March 23, 2006
Perivascular tissue pharmacokinetics of dipyridamoleKosalaram Goteti, Takahisa Masaki, Tadashi Kuji, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 15, 1988
Il-4 is an endogenous T cell growth factor during the immune response to a syngeneic retrovirus-induced tumorD E Kern, D J Peace, J P Klarnet, et al.
Journal of General Internal Medicine|July 1, 2006
Residents' perceptions of professionalism in training and practice: barriers, promoters, and duty hour requirementsNeda Ratanawongsa, Shari Bolen, Eric E Howell, et al.
Journal of Pharmaceutical and Biomedical Analysis|December 3, 2014
Isolation and structural characterization of a new tadalafil analog (2-hydroxyethylnortadalafil) found in a dietary supplementSara E Kern, Elisa A Nickum, Rick A Flurer, et al.
Military Medicine|November 6, 2014
The incidence of early and recurrent urinary tract infections after midurethral sling operationsAlan P Gehrich, Jason R Patzwald, Molly E Kern, et al.
Scandinavian Journal of Gastroenterology|July 11, 2001
Ulcerative colitis and colorectal carcinoma: DNA-profile, laminin-5 gamma2 chain and cyclin A expression as early markers for risk assessmentJ Habermann, C Lenander, U J Roblick, et al.
Pageof 65